Table 1. The proportion of patients self-reporting long COVID-associated symptoms
From: Long-term perturbation of the peripheral immune system months after SARS-CoV-2 infection
Number of Subjects | Percent of subjects | ||
|---|---|---|---|
General | Referred to long COVID clinic | 21 | 30.4 |
Any reported symptoms? | 33 | 57.9 | |
Non-specific | Fatigue | 23 | 40.4 |
Dyspnoea | 20 | 35.1 | |
Decreased muscle strength | 19 | 33.3 | |
Worsened sleep quality | 16 | 28.1 | |
Palpitations | 4 | 7.0 | |
Dizziness | 4 | 7.0 | |
Hair loss | 6 | 10.5 | |
Neuropsychiatric | Anxiety/depression | 14 | 24.6 |
Worsened memory/concentration | 20 | 35.1 | |
Pain | Headache | 10 | 17.5 |
Chest pain | 7 | 12.3 | |
Joint pain | 6 | 10.5 | |
Myalgia | 6 | 10.5 | |
Oral/pharyngeal | Worsened sense of smell/taste | 11 | 19.3 |
Difficulty swallowing /sore throat | 5 | 8.8 | |
Gastrointestinal | Diarrhoea | 4 | 7.0 |
Nausea | 3 | 5.3 | |
Vomiting | 1 | 1.8 |